Rosana Crespo

Dr. Rosana Crespo


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
MCMaría A. Castro
María A. Castro
MLManuel A. Llanos
Manuel A. Llanos
Boris Rodenak-KladniewBoris Rodenak-Kladniew
Boris Rodenak-Kladniew
LGLuciana Gavernet
Luciana Gavernet
MGMarianela E. Galle
Marianela E. Galle
Rosana CrespoRosana Crespo
Rosana Crespo

25 April 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
SASol Micaela Angulo
Sol Micaela Angulo
VOVictoria Belen Occhieppo
Victoria Belen Occhieppo
CMCristian Moya
Cristian Moya
Rosana CrespoRosana Crespo
Rosana Crespo
Claudia BregonzioClaudia Bregonzio
Claudia Bregonzio
Background: Anxiety disorders have a 7.3% worldwide prevalence and, considering the long period of treatment, developing new efficient and safer pharmacological tools is critical. Essential oils consist of highly concentrated lipophilic compounds from plants with therapeutic potential effects, such as Lavandula burnatii, produced in Córdoba, Argentine, with high levels of active pharmaceutical ingredients in its essential oil (linalyl acetate and linalool). The evidence indicates that lavender essential oil could induce anxiolytic effects; however, more systematic studies are needed. Methods: To test the anxiolytic attributes of Lavandula burnatii, male Wistar rats (200–260 g) were injected intraperitoneally with two different doses of essential oil (30/80 mg/kg) or vehicle (Myritol 318, a high-purity vegetable oil), once (acute) or for 7 days. One hour after the last administration, the anxiolytic effects were evaluated using the following behavioral tests: the dark–light test and the elevated plus maze test. The open-field test was used to assess locomotor activity. Results: Our results showed that the lower dose of lavender essential oil induces anxiolytic effects since it increases the time spent in the aversive compartment in each evaluation. The acute administration has no impact on the behaviors evaluated. The higher dose is comparable with the control group and does not show significant differences. Conclusions: More studies are needed to better characterize the beneficial effects of this essential oil for anxiety disorders and to establish an adequate dosage range.

22 March 2025 in Plants
Verified
Journal Article
Open access
PDF file
MCMatías Jávega Cometto
Matías Jávega Cometto
Aracely Janneth Naranjo ViteriAracely Janneth Naranjo Viteri
Aracely Janneth Naranjo Viteri
LCLeandro Gabriel Champarini
Leandro Gabriel Champarini
CHClaudia Hereñu
Claudia Hereñu
Rosana CrespoRosana Crespo
Rosana Crespo
Monoterpenes (MTs) are plants’ secondary metabolites and major components of essential oils (EOs), widely used in the pharmaceutical industry. However, its neuroprotective effects, particularly in Parkinson’s disease (PD) have not been fully demonstrated. PD is a progressive neurological disorder marked by dopaminergic neuron loss in the substantia nigra, motor symptoms being the most reported ones. This review evaluates the evidence supporting the use of MTs as potential neuroprotective agents. PubMed, SCOPUS, Google Scholar, and ScienceDirect databases were searched for articles on MTs in murine models with any type of administration. The PRISMA guidelines were followed. After screening 405 records, 32 were included in the systematic review and 30 were included in the meta-analysis. Fifteen MTs, commonly found in EOs, were identified as potential therapeutic agents for PD. The meta-analysis revealed that MTs administration improved motor performance, increased tyrosine hydroxylase levels, reduced oxidative stress markers (malondialdehyde) and proinflammatory cytokines (IL-6, IL-1, TNF-α), and enhanced antioxidant enzymes (catalase, superoxide dismutase) in parkinsonian animals. The antioxidant and anti-inflammatory properties of MTs appear to be key mechanisms in mitigating dopaminergic neurodegeneration. However, further clinical research is essential to translate these findings into practical applications.

27 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SASol Micaela Angulo
Sol Micaela Angulo
VOVictoria Belen Occhieppo
Victoria Belen Occhieppo
CMCristian Moya
Cristian Moya
Rosana CrespoRosana Crespo
Rosana Crespo
Claudia BregonzioClaudia Bregonzio
Claudia Bregonzio
Background: Anxiety disorders have a 7.3% worldwide prevalence and, considering the long period of treatment, developing new efficient and safer pharmacological tools is critical. Essential oils consist of highly concentrated lipophilic compounds from plants with therapeutic potential effects—Lavandula burnatii, produced in Córdoba with high levels of active pharmaceutical ingredients. The evidence indicates that lavender essential oil could induce anxiolytic effects, however, more systematic studies are needed. Methods: To test the anxiolytic attributes of Lavandula burnatii, male Wistar rats (200-260g) were injected intraperitoneally with 2 different doses of essential oil (30 /80 mg/Kg) or vehicle (Myritol 318, a high-purity vegetable oil), once (acute) or for 7 days. One hour after the last administration, the anxiolytic effects were evaluated using the following behavioral tests: dark-light box and elevated plus maze. The open-field test was used to assess locomotor activity. Results: Our results showed that the lower dose of lavender essential oil induces anxiolytic effects since it increases the time spent in the aversive compartment in each evaluation. The acute administration has no impact on the behaviors evaluated. The higher dose is comparable with the control group and does not show significant differences. Conclusion: More studies are needed to better characterize the beneficial effects of this essential oil for anxiety disorders and to establish an adequate dosage range.